Liu Yan-Xia, Zhang Feng, Yao Qing-Min, Yuan Ting, Xu Jian, Zhu Xiao-Juan
Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250021, China.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15642-51. eCollection 2015.
Recent research demonstrates that the underlying mechanism in immune thrombocytopenia (ITP) is very complex. Lymphocyte function associated antigen-1 (LFA-1) plays important roles in autoimmune diseases. The purpose of this study was to investigate the expression of CD11a on lymphocytes and explore its possible role in ITP. The expression of CD11a on lymphocyte subpopulations (CD3(+) T cells, CD3(+)CD4(+) T cells, CD3(+)CD4(-) T cells, CD4(+)Foxp3(+) T regulatory cells and CD19(+) B cells) were analyzed by flow cytometry. Specific anti-platelet GPIIb/IIIa and/or GPIb/IX autoantibodies were assayed by modified monoclonal antibody specific immobilization of platelet antigens (MAIPA). The mean fluorescence intensity of CD11a on CD3(+) T, CD3(+)CD4(-) T and CD19(+) B lymphocytes were increased in ITP patients compared to healthy controls. No significant difference of CD11a expression on CD3(+)CD4(+) T cells or CD4(+)Foxp3(+) T regulatory cells was found between ITP patients and controls. Our data indicates the possible role of CD11a in the pathogenesis of ITP.
近期研究表明,免疫性血小板减少症(ITP)的潜在机制非常复杂。淋巴细胞功能相关抗原-1(LFA-1)在自身免疫性疾病中发挥重要作用。本研究旨在探讨淋巴细胞上CD11a的表达情况,并探索其在ITP中的可能作用。采用流式细胞术分析淋巴细胞亚群(CD3(+) T细胞、CD3(+)CD4(+) T细胞、CD3(+)CD4(-) T细胞、CD4(+)Foxp3(+) T调节细胞和CD19(+) B细胞)上CD11a的表达。通过改良的血小板抗原单克隆抗体特异性固定法(MAIPA)检测特异性抗血小板糖蛋白IIb/IIIa和/或糖蛋白Ib/IX自身抗体。与健康对照相比,ITP患者CD3(+) T、CD3(+)CD4(-) T和CD19(+) B淋巴细胞上CD11a的平均荧光强度增加。ITP患者与对照之间在CD3(+)CD4(+) T细胞或CD4(+)Foxp3(+) T调节细胞上CD11a表达无显著差异。我们的数据表明CD11a在ITP发病机制中可能发挥作用。